摘要
目的:探讨肾细胞癌中脆性组氨酸三联体(fragile histidine triad,FHIT)基因蛋白表达状况及其与临床病理的关系。方法:采用兔抗人FHIT蛋白抗体和枸橼酸-微波-SP免疫组化方法检测86例肾细胞癌、52例癌旁组织和10例肾组织中FHIT的表达状况,并分析其与组织学分级、临床分期以及5年生存率的关系。结果:肾细胞癌FHIT表达较癌旁组织和正常肾组织明显降低,H=69·421,P=0·000。FHIT蛋白表达在肾癌组织学分型(H=11·557,P=0·003)、分级(H=13·402,P=0·001)及临床分期(H=18·168,P=0·000)中差异均有统计学意义。FHIT蛋白表达强阳性组患者5年生存率显著高于弱阳性及阴性组,Z=-2·390,P=0·017。结论:FHIT低表达或缺失可能提示其抑癌功能丧失,对肾细胞癌的发生和演化具有重要作用。FHIT表达缺失可能成为辅助肾细胞癌诊断及预后的一个新标记。肿瘤防治杂志,2005,12(19)
OBJECTIVE: To investigate the expression of fragile histidine triad (FHIT) gene protein, and the possible relationship between FHIT expression and clinicopathologieal indices in renal cell carcinoma. METHODS: FHIT protein expression was detected in 86 renal cell carcinomas,52 adjacent non-neoplastic tissues and 10 normal kidney tissues formalin-fixed, paraffin-embedded tissues by the citratemicrowave-SP immunohistochemical method, and the relationship between it and histological grade, clinical stage and 5-year survival rate was analysed RESULTS: Thirty paint two percent (26/86) of renal cell carcinomas, 100. 0% (52/52) of parameoplastie tissues and 100.0% (10/10) of normal kidney tissues showed a strongly positive staining pattern of FHIT protein. There was a significant difference in FHIT expression between carcinomas and adjacent non-neoplastic tissues or normal kidney, H = 69. 421, P = 0. 000. Carcinomas with decreased expression of FHIT were corresponding to the histological type ( H= 11. 557, P=0.003), histological grade (H=13.402, P=0.001), clinical stage (H=18. 168, P=0.000) and 5-year survival rate (Z= -2. 390, P=0.017), respectively. CONCLUSION: The loss of expression of FHIT may be associated with the carcinogenesis of tubule epithelia, the development and the prognosis of the tumor, thus may become a new adjunct diagnostic and prognostic marker in renal cell carcinoma.
出处
《肿瘤防治杂志》
2005年第19期1486-1488,共3页
China Journal of Cancer Prevention and Treatment
关键词
癌
肾细胞/治疗
肾肿瘤/病理学
免疫学试验
存活率
carcinoma, renal cell/therapy
kidney neoplasms/pathology
immunologic tests
survival rate